{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:11:42Z","timestamp":1793157102750,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["BX20230434"],"award-info":[{"award-number":["BX20230434"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82401261"],"award-info":[{"award-number":["82401261"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171058"],"award-info":[{"award-number":["82171058"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M743952"],"award-info":[{"award-number":["2023M743952"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011790","name":"Xiangya Hospital, Central South University","doi-asserted-by":"publisher","award":["2023Q12"],"award-info":[{"award-number":["2023Q12"]}],"id":[{"id":"10.13039\/501100011790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFA1108704"],"award-info":[{"award-number":["2024YFA1108704"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFA1108700"],"award-info":[{"award-number":["2024YFA1108700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.mtbio.2025.102304","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:44:09Z","timestamp":1758617049000},"page":"102304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Bilirubin-polymer nanocarriers enable targeted farrerol delivery for glaucoma neuroprotection via Nrf2-mediated ferroptosis\/apoptosis inhibition"],"prefix":"10.1016","volume":"35","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10414","key":"10.1016\/j.mtbio.2025.102304_bib1","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(23)01289-8","article-title":"Glaucoma: now and beyond","volume":"402","year":"2023","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.mtbio.2025.102304_bib2","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.mtbio.2025.102304_bib3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/0003-4819-158-4-201302190-00008","article-title":"Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the U.S. Preventive Services Task Force","volume":"158","author":"Boland","year":"2013","journal-title":"Ann. Intern. Med."},{"issue":"11","key":"10.1016\/j.mtbio.2025.102304_bib4","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1167\/iovs.07-1661","article-title":"Intraocular pressure elevation induces mitochondrial fission and triggers OPA1 release in glaucomatous optic nerve","volume":"49","author":"Ju","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102304_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0039-6257(05)80042-6","article-title":"Mechanisms of optic nerve damage in primary open angle glaucoma","volume":"39","author":"Fechtner","year":"1994","journal-title":"Surv. Ophthalmol."},{"issue":"9422","key":"10.1016\/j.mtbio.2025.102304_bib6","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(04)16257-0","article-title":"Primary open-angle glaucoma","volume":"363","author":"Weinreb","year":"2004","journal-title":"Lancet Lond. Engl."},{"issue":"8","key":"10.1016\/j.mtbio.2025.102304_bib7","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.3390\/jcm13082214","article-title":"Optic nerve neuroprotection in glaucoma: a narrative review","volume":"13","author":"D'Angelo","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.mtbio.2025.102304_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101193","article-title":"Neuroprotection in glaucoma: mechanisms beyond intraocular pressure lowering","volume":"92","author":"Tribble","year":"2023","journal-title":"Mol. Aspects Med."},{"issue":"5","key":"10.1016\/j.mtbio.2025.102304_bib9","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.exer.2010.08.009","article-title":"Neuroprotection in glaucoma - is there a future role?","volume":"91","author":"Baltmr","year":"2010","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102304_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.preteyeres.2011.11.002","article-title":"The molecular basis of retinal ganglion cell death in glaucoma","volume":"31","author":"Almasieh","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mtbio.2025.102304_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1703810","article-title":"Involvement of Nrf2 in ocular diseases","volume":"2017","author":"Batliwala","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.mtbio.2025.102304_bib12","article-title":"The potential role of nuclear factor erythroid 2-related factor 2 (Nrf2) in glaucoma: a review","volume":"26","author":"Wang","year":"2020","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"issue":"7","key":"10.1016\/j.mtbio.2025.102304_bib13","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.18240\/ijo.2024.07.21","article-title":"Regulatory factors of Nrf2 in age-related macular degeneration pathogenesis","volume":"17","author":"Hu","year":"2024","journal-title":"Int. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.mtbio.2025.102304_bib14","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","article-title":"Nrf2-Keap1 signaling in oxidative and reductive stress","volume":"1865","author":"Bellezza","year":"2018","journal-title":"Biochim. Biophys. Acta BBA - Mol. Cell Res."},{"key":"10.1016\/j.mtbio.2025.102304_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102389","article-title":"Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway","volume":"54","author":"Liu","year":"2022","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102304_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019456","article-title":"Age-related retinopathy in NRF2-deficient mice","volume":"6","author":"Zhao","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.mtbio.2025.102304_bib17","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1167\/iovs.04-1369","article-title":"Flavonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death","volume":"47","author":"Hanneken","year":"2006","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"18","key":"10.1016\/j.mtbio.2025.102304_bib18","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1042\/CS20171182","article-title":"Trimetazidine protects retinal ganglion cells from acute glaucoma via the Nrf2\/Ho-1 pathway","volume":"131","author":"Wan","year":"2017","journal-title":"Clin. Sci. Lond. Engl."},{"key":"10.1016\/j.mtbio.2025.102304_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113378","article-title":"Nuclear factor erythroid 2-related factor 2 agonist protects retinal ganglion cells in glutamate excitotoxicity retinas","volume":"153","author":"An","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.mtbio.2025.102304_bib20","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.3390\/ijms20123056","article-title":"The potential of flavonoids for the treatment of neurodegenerative diseases","volume":"20","author":"Maher","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2025.102304_bib21","series-title":"Role of Flavonoids in Age-Related Macular Degeneration","author":"Sun","year":"2023"},{"issue":"12","key":"10.1016\/j.mtbio.2025.102304_bib22","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1167\/iovs.05-0397","article-title":"Flavonoids protect retinal ganglion cells from oxidative stress\u2013induced death","volume":"46","author":"Maher","year":"2005","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"10.1016\/j.mtbio.2025.102304_bib23","doi-asserted-by":"crossref","unstructured":"X. Qin et al., \u201cThe pharmacological properties and corresponding mechanisms of farrerol: a comprehensive review,\u201d Pharm. Biol., vol. 60, no. 1, pp. 9\u201316, doi: 10.1080\/13880209.2021.2006723.","DOI":"10.1080\/13880209.2021.2006723"},{"key":"10.1016\/j.mtbio.2025.102304_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.biopha.2018.10.053","article-title":"Farrerol attenuates \u03b2-amyloid-induced oxidative stress and inflammation through Nrf2\/Keap1 pathway in a microglia cell line","volume":"109","author":"Cui","year":"2019","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"10.1016\/j.mtbio.2025.102304_bib25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ejphar.2015.07.012","article-title":"Anti-inflammatory effects of farrerol on IL-1\u03b2-stimulated human osteoarthritis chondrocytes","volume":"764","author":"Zhang","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.mtbio.2025.102304_bib26","first-page":"278","article-title":"Farrerol overcomes the invasiveness of lung squamous cell carcinoma cells by regulating the expression of inducers of epithelial mesenchymal transition","volume":"131","author":"Li","year":"2019","journal-title":"Microb. Pathog."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102304_bib27","doi-asserted-by":"crossref","first-page":"511","DOI":"10.33549\/physiolres.935040","article-title":"Farrerol alleviates hypoxic-ischemic encephalopathy by inhibiting ferroptosis in neonatal rats via the Nrf2 pathway","volume":"72","author":"Li","year":"2023","journal-title":"Physiol. Res."},{"key":"10.1016\/j.mtbio.2025.102304_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8847844","article-title":"Farrerol enhances Nrf2-mediated defense mechanisms against hydrogen peroxide-induced oxidative damage in human retinal pigment epithelial cells by activating Akt and MAPK","volume":"2021","author":"Ma","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.mtbio.2025.102304_bib29","first-page":"301","article-title":"Review: R28 retinal precursor cells: the first 20 years","volume":"20","author":"Seigel","year":"2014","journal-title":"Mol. Vis."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102304_bib30","article-title":"Expression of glial markers in a retinal precursor cell line","volume":"2","author":"Seigel","year":"1996","journal-title":"Mol. Vis."},{"issue":"9","key":"10.1016\/j.mtbio.2025.102304_bib31","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/cells13090775","article-title":"Neuroretinal cell culture model as a tool for the development of new therapeutic approaches for oxidative stress-induced ocular diseases, with a focus on glaucoma","volume":"13","author":"Fomo","year":"2024","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.mtbio.2025.102304_bib32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41419-022-04911-9","article-title":"Inhibiting multiple forms of cell death optimizes ganglion cells survival after retinal ischemia reperfusion injury","volume":"13","author":"Qin","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mtbio.2025.102304_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102541","article-title":"Inhibition of ferroptosis promotes retina ganglion cell survival in experimental optic neuropathies","volume":"58","author":"Guo","year":"2022","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102304_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41418-022-01046-4","article-title":"Pathologically high intraocular pressure disturbs normal iron homeostasis and leads to retinal ganglion cell ferroptosis in glaucoma","volume":"30","author":"Yao","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mtbio.2025.102304_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173208","article-title":"Neuroprotection: a versatile approach to combat glaucoma","volume":"881","author":"Naik","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.mtbio.2025.102304_bib36","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1007\/s12035-024-04031-9","article-title":"Farrerol alleviates cerebral ischemia-reperfusion injury by promoting neuronal survival and reducing neuroinflammation","volume":"61","author":"Zhao","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mtbio.2025.102304_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105739","article-title":"Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-\u03baB signaling pathways","volume":"75","author":"Li","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.mtbio.2025.102304_bib38","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.3390\/nu12103158","article-title":"Natural products: evidence for neuroprotection to Be exploited in glaucoma","volume":"12","author":"Adornetto","year":"2020","journal-title":"Nutrients"},{"issue":"Sep","key":"10.1016\/j.mtbio.2025.102304_bib39","article-title":"Ozone pretreatment alleviates ischemiareperfusion injury-induced myocardial ferroptosis by activating the Nrf2\/Slc7a11\/Gpx4 axis","volume":"165","author":"S","year":"2023","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102304_bib40","article-title":"Identifying key antioxidative stress factors regulating Nrf2 in the genioglossus with human umbilical cord mesenchymal stem-cell therapy","volume":"14","author":"H","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102304_bib41","article-title":"NRF2 activation ameliorates blood-brain barrier injury after cerebral ischemic stroke by regulating ferroptosis and inflammation","volume":"14","author":"W","year":"2024","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102304_bib42","article-title":"Regulating Nrf2 activity: ubiquitin ligases and signaling molecules in redox homeostasis","volume":"50","author":"Jd","year":"2025","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.mtbio.2025.102304_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.actbio.2021.02.017","article-title":"Nanomedicines for the treatment of glaucoma: current status and future perspectives","volume":"125","author":"Zhai","year":"2021","journal-title":"Acta Biomater."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102304_bib44","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/bjophthalmol-2013-304028","article-title":"Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine","volume":"98","author":"Kim","year":"2014","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102304_bib45","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.apsb.2016.09.001","article-title":"Nanotechnology-based strategies for treatment of ocular disease","volume":"7","author":"Weng","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"issue":"30","key":"10.1016\/j.mtbio.2025.102304_bib46","article-title":"Retinal microenvironment-protected Rhein-GFFYE nanofibers attenuate retinal ischemia-reperfusion injury via inhibiting oxidative stress and regulating microglial\/macrophage M1\/M2 polarization","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci. Weinh. Baden-Wurtt. Ger."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102304_bib47","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/10717544.2020.1731861","article-title":"Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy","volume":"27","author":"Li","year":"2020","journal-title":"Drug Deliv."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425008749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425008749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:31:31Z","timestamp":1778905891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006425008749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":47,"alternative-id":["S2590006425008749"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.102304","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bilirubin-polymer nanocarriers enable targeted farrerol delivery for glaucoma neuroprotection via Nrf2-mediated ferroptosis\/apoptosis inhibition","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.102304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102304"}}